title: [Cost reduction in drug therapy of diabetes].
abstract: The costs of control an therapy of diabetes mellitus are very expensive. A cost reduction is to be expected after successful therapy. For 1024 insulin dependent type I-diabetics with stable insulin requirements the mean costs remained unchanged. 456 insulin dependent type II-diabetics who reduced weight showed a slight reduction of mean costs. The cost of drug therapy were significantly reduced for 535 overweight type II-diabetics under different therapeutic modalities, who reached a weight reduction. The inpatient treatment of diabetes influences the costs of drug therapy. A cost reduction is to be expected for overweight type II-diabetics, who can reach a weight reduction.
authors.forename: R
authors.initials: R
authors.lastname: Petzoldt
authors.forename: B
authors.initials: B
authors.lastname: Oeynhausen
mesh_terms: D003363:Cost Control / Q000639:trends; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000191:economics; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000191:economics; D005860:Germany, West; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D015431:Weight Loss
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin
vernacular_title: Kostensenkung bei der medikamentösen Diabetestherapie.